ABCB5 and melanoma: ABCB5, a tumour initiating or “stem cell” marker known to be involved in tumour resistance to chemotherapy and targeted therapy in melanoma, identifies a subset of slow-cycling tumour cells with increased potential to initiate metastases [44, 50, 56].